African Scientists to be Profiled at Landmark Scientific Meeting
African Scientists to be Profiled at Landmark Scientific Meeting

African Scientists to be Profiled at Landmark Scientific Meeting

Friday, August 2, 2019

Three-day meeting to profile scientific research by Masters, PhD and Post-doctoral researchers

across 21 African countries including South Africa 

JOHANNESBURG, South Africa – July 15, 2019 – Scientists from South Africa will be among

300 health scientists from Africa and other parts of the world that will gather at a landmark

scientific gathering between July 15 and 17 in Dakar, Senegal to showcase ground-breaking

research aimed at reducing Africa’s disease burden and creating healthier communities.

Scientific breakthroughs to be discussed at the meeting include progress being made on

research towards an HIV cure and early detection tools for cancer and malaria. 

The DELTAS Africa Scientific Conference, themed, ‘ A critical mass: developing world class research leaders’ will be the first in Francophone Africa, demonstrating The African Academy

of Science’s commitment to break language and geographical barriers and help foster intraAfrican collaboration.

It is being organised through a partnership between the Senegal based DELTAS Africa network and related Francophone-based programmes including The Malaria Research Capacity Development (MARCAD).

“The conference represents a unique opportunity to demonstrate the value of investing i n science

and in training a critical mass of scientific leaders in Africa,” says The AAS Deputy Director of

DELTAS Africa Programme Manager Alphonsus Neba. “DELTAS Africa is creating professional

cutting-edge research environments that will be sustained long after the programme has ended

and provide conducive environments to do great science,” he adds

Among scientists from South Africa who will be profiled at the meeting are Nicole De Wet, a

Postdoctoral Fellow studying the causes of risk-taking behaviour among adolescents in South

Africa and Prof Jonathan Levin who is investigating mental health among HIV-infected children

and adolescents in Uganda.

The convening will be the third Annual Grantees’ Meeting of The Developing Excellence in

Leadership, Training and Science (DELTAS Africa) programme; a US$100 million programme

of The African Academy of Sciences supporting the Africa-led development of world-class

scientific leaders through health research support, training fellowships, mentorship, and

investments in research infrastructure in 12 programmes spanning 21 countries. Notable

attendees will include the Father of Africa Genomics, Charles Rotimi from the National Institute

of Health and the 2008 Nobel Laureate in Chemistry, Marty Chalfie. 

DELTAS Africa’s goal is to produce a critical mass of new cadre health researchers and

scientists who will be at the forefront of cutting-edge research, influencing local health policy

and driving a locally relevant health research agenda for Africa. The DELTAS Africa Scientific

Conference will mark a major milestone in the run-up to this critical objective.

Among the programme’s achievements to date:  

  • Close to  1,500 master’s, PhD and postdoctoral trainees, half of whom are women, have been recruited in the four years of the programme and have collectively published 493 papers in high impact journals  
  • With close to 348 PhD and postdoctoral Fellows registered in institutions outside their home countries, the programme is also promoting intra-Africa collaboration, which is important to mobilise political support for research, to pool scant resources and maximise impact for shared challenges.    

The 12  programmes have collectively attracted additional 298 grants worth over $227 million and received 153 prizes and awards worth $9.3million in recognition of their scientific excellence. 

The meeting will also provide a platform for over 200 DELTAS Africa funded fellows and

researchers – specifically Masters, PhD and Post-doctoral trainees from its 11 programmes

spanning Kenya, Mali, Senegal, Côte d’Ivoire, Ghana, South Africa, Uganda, and Zimbabwe –

to showcase scientific outcomes and likely impact of their health research. 

Scientific breakthroughs to be discussed at the meeting include progress being made on

research towards an HIV cure in South Africa, and efforts towards the development of a lowcost HIV drug

resistance assay (70% lower cost - from $100-$200 to $40-$70), that could substantially reduce the

cost of HIV drug resistance surveillance in Africa.

PhD scientist Mohanad Mohamed in South Africa has used next generation gene expression

data to develop cancer disease classification models combining both machine learning and

statistical approaches for high dimensional data. The models being developed by Mohanad

Mohammed can potentially be used by researchers and oncologists to aid in formulating

strategies for early diagnosis and treatment of cancer particularly in Sub-Saharan Africa where

the burden of NCDs is on the rise.

The gathering will also highlight successes such as the work in Mali of Dr Drissa Coulibaly, a

MARCAD postdoc fellow and medical doctor specialising in parasitology, who is currently

researching malaria distribution in time and space as a key element of guiding malaria control

programmes across the continent. 

 “DELTAS Africa is supporting us to create the skilled manpower that Senegal and indeed,

Africa needs to address health challenges that are contributing to an uneven global disease

burden. We are proud to be part of the programme and are seeing the fruits of investing in

science through the numbers of women and postgraduate trainees we have recruited and the

impactful research they are conducting,” says MARCAD Director, Prof  Oumar Gaye.

ORGANISATIONAL PROFILES

CARTA 

The Consortium for Advanced Research Training in Africa (CARTA) is a South-South

partnership with South-North collaboration. CARTA is jointly-led by the African Population and

Health Research Center (APHRC), Kenya, and the University of Witwatersrand (Wits), South

Africa. These institutions share more than 15 years of successful collaboration. APHRC

provides a highly productive research environment, with a multidisciplinary team of highly

qualified researchers from across sub-Saharan Africa. Wits provides the institutional capacity of

an internationally rated, research-led, postgraduate-oriented African university. Both institutions

are internationally-recognised as leaders in research and training, have championed the cause

of higher education in Africa, have facilitated several partnerships and initiatives that strengthen

collaborations among different universities and research organisations, and have strong

systems of accountability. The African-led nature of CARTA and its focus on sustainable,

measurable changes in research capacity and output are in tandem with the current emphasis

on homegrown and intellectually sound solutions to the problem of sustainable capacity for

research for health and development in Africa. Since 2008, CARTA, a consortium of 9 African

universities, 4 African research centres and 7 non-African partners, has been pursuing the goal

of re-launching African universities as central actors in the production of rigorous high-quality

research for Africa’s development. 

Website: http://www.cartafrica.org/ 

Twitter: @CARTAfrica 

Facebook: Consortium for Advanced Research Training in Africa - CARTA 

SANTHE 

The Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE) is a network

African-led research in HIV (particularly acute HIV (AHI)) and Tuberculosis (TB) infection. We

aim to shape and drive locally relevant basic, clinical and translational research in Africa

through: 

• A cutting-edge HIV and TB research programme.

• An innovative training and capacity building programme.

• The facilitation of a strong institutional network for research excellence as a pathway to 

intellectual and financial independence for African researchers and their instit utions.

• Community engagement to ensure meaningful translational research and public health 

and community impact. 

These goals will be achieved by the strengthening of South-South partnerships, the creation of

enabling environments for excellence in research in Africa and the high level training of the 

next-generation leaders of African science. This consortium is specifically focused on HIV and

TB as this syndemic is a public health crisis in Africa that requires the full weight of basic

science, translational/clinical research, and political and social mobilisation.

Located at the epicentre of the HIV/AIDS and TB epidemics, SANTHE’s African partner sites

are collectively and extensively experienced in research and training, and have multidisciplinary

expertise in microbiology, immunology, epidemiology and clinical trials. SANTHE is further

strengthened through the support of various international collaborating partners and aims to

actively grow its membership – within the borders of Africa and beyond.

Website: www.santheafrica.org

Twitter: www.twitter.com/SANTHEafrica

Facebook: www.facebook.com/SANTHEafrica 

Read more ...